SecProbe.io - Probe Score Transparency

Probe Score Transparency

Tenaya Therapeutics, Inc. (TNYA)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence

Probe Score

3.5 / 10

Letters

2

Latest Activity

Sep. 10, 2025

Version

v1

Score Breakdown

Letter Count

2.0

Sentiment / Tone

1.5

Keywords

0.0

Signals

0.0

Notable 8-K Modifier

0.0

Notable 8-K Count

0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

Date	Form	Sentiment	Urgency	Summary	Open
Sep. 10, 2025	UPLOAD	Neutral/Informational	Low	The SEC has completed its review of Tenaya Therapeutics, Inc.'s Form 10-K for the year ended December 31, 2024. They remind the company and its management of their responsibility …	Read Filing EDGAR
Sep. 4, 2025	CORRESP	Concern from SEC	Moderate	The correspondence from Tenaya Therapeutics, Inc. addresses comments from the SEC regarding their Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The SEC r…	Read Filing EDGAR
Aug. 26, 2025	UPLOAD	Concern from SEC	High	The SEC has reviewed Tenaya Therapeutics, Inc.'s Form 10-K for the year ended December 31, 2024, and has issued comments requiring clarification on certain disclosures. Specifical…	Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.